Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share (APVO)
CUSIP: 03835L405
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common stock, par value $0.001 per share
- Shares outstanding
- 3,581,500
- Total 13F shares
- 10,000
- Share change
- -9,629
- Total reported value
- $30,500
- Price per share
- $3.05
- Number of holders
- 1
- Value change
- +$7,731
- Number of buys
- 1
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 03835L405?
CUSIP 03835L405 identifies APVO - Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03835L405:
Top shareholders of APVO - Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| YA II PN, Ltd. |
13D/G
|
— |
10%
|
357,842
|
$1,663,965 | $0 | 16 Jun 2025 | |
| CVI Investments, Inc. |
13D/G
|
— |
9.9%
|
357,842
|
$1,073,526 | $0 | 30 Jun 2025 | |
| Ayrton Capital LLC |
13D/G
|
— |
10%
|
358,150
|
$107,445 | $0 | 30 Jun 2025 | |
| Hudson Bay Capital Management LP |
13D/G
|
— |
5%
|
76,598
|
$52,853 | $0 | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.29%
|
10,526
|
$12,210 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.09%
|
3,255
|
$3,776 | — | 31 Mar 2025 | |
| CLEAR STREET LLC |
13F
|
Company |
0.08%
|
2,800
|
$3,248 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
2,318
|
$2,689 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0.02%
|
701
|
$813 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0%
|
24
|
$28 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
4
|
$4 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Mar 2025 | |
| L1 Capital Global Opportunities Master Fund, Ltd. |
13D/G
|
— |
7.6%
|
421,000
|
— | +$39,294 | 21 Apr 2025 | |
| BIGGER CAPITAL FUND L P |
13D/G
|
— |
10%
|
285,000
|
— | $0 | 18 Jun 2025 | |
| Fuad El-Hibri |
3/4/5
|
Director |
—
class O/S missing
|
87,697
|
— | — | 03 Dec 2021 |
Institutional Holders of Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share (APVO) as of Q2 2025
As of 30 Jun 2025,
Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share (APVO) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
10,000 shares.
The largest 1 holders included
Birchview Capital, LP.
This page lists
1
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
8
Q2 2025 holders
1
Holder diff
-7
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.